Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
about
Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Mesenchymal stem cell deficien ...... with immune thrombocytopenia.
@en
Mesenchymal stem cell deficien ...... with immune thrombocytopenia.
@nl
type
label
Mesenchymal stem cell deficien ...... with immune thrombocytopenia.
@en
Mesenchymal stem cell deficien ...... with immune thrombocytopenia.
@nl
prefLabel
Mesenchymal stem cell deficien ...... with immune thrombocytopenia.
@en
Mesenchymal stem cell deficien ...... with immune thrombocytopenia.
@nl
P2093
P2860
P356
P1476
Mesenchymal stem cell deficien ...... s with immune thrombocytopenia
@en
P2093
Chen-Cong Wang
Fei-Er Feng
Hai-Xia Fu
Jia-Min Zhang
Kai-Yan Liu
Lan-Ping Xu
Lin-Lin Xu
Qian-Ming Wang
Xiao-Lu Zhu
P2860
P304
P356
10.1111/BJH.15034
P407
P577
2018-01-12T00:00:00Z